Clovis to offer $250M in new stock and debts in shelf offer
BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) is offering an additional $250 million in new stock and debt options after it raised around $225 million in August.
The Boulder-based oncology company is raising the funds through new stock sales, share warrants and debt securities, according to filings with the U.S. Securities and Exchange Commission Monday afternoon.
The shares were submitted in a “shelf offering,” which allows Clovis to sell them over the next three years.
In its filing, Clovis said the funds would be used for a range of corporate purposes, including debt repayment or…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!